2426 - 2450 of 8826 Results
Title
Year
-
OPENTitle: A Possible Novel Anti-Inflammatory Mechanism for the Pharmacological Prolyl Hydroxylase Inhibitor 3,4-Dihydroxybenzoate: Implications for Use as a Therapeutic for Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 12Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/364684Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/364684.pdfCitation Count: 17
-
RESTRICTEDTitle: A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeysJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 39Issue #: 3Start Page: 352End Page: 361Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2010.05.001Best OA location URL: https://doaj.org/article/63e10c65eb3f433c933e3bf217f2f015Citation Count: 150
-
OPENTitle: Executive functioning and risk-taking behavior in Parkinson’s disease patients with impulse control disordersJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 123Issue #: 6Start Page: 573End Page: 581Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-016-1549-yBest OA location URL: https://hal.sorbonne-universite.fr/hal-01311564Citation Count: 15
- Reply to letter to the editor “Adaptive DBS in Parkinson's disease: Headlines, perspectives and challenges”2019RESTRICTEDTitle: Reply to letter to the editor “Adaptive DBS in Parkinson's disease: Headlines, perspectives and challenges”Journal Name: Brain StimulationPublisher: Elsevier BVVol: 12Issue #: 5Start Page: 1330End Page: 1331Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2019.06.014Citation Count: 0
-
OPENTitle: Model-Based Comparison of Deep Brain Stimulation Array Functionality with Varying Number of Radial Electrodes and Machine Learning Feature SetsJournal Name: Frontiers in Computational NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncom.2016.00058Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncom.2016.00058/pdfCitation Count: 41
- Leucine‐rich repeat kinase 2‐sensitive Na + /Ca 2+ exchanger activity in dendritic cells2015RESTRICTEDTitle: Leucine‐rich repeat kinase 2‐sensitive Na + /Ca 2+ exchanger activity in dendritic cellsJournal Name: The FASEB JournalPublisher: WileyVol: 29Issue #: 5Start Page: 1701End Page: 1710Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fj.14-264028Citation Count: 19
-
OPENTitle: A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed CellsJournal Name: Angewandte Chemie International EditionPublisher: WileyVol: 62Issue #: 40Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/anie.202309306Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/anie.202309306Citation Count: 9
-
RESTRICTEDTitle: Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 47Issue #: 3Start Page: 393End Page: 406Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2012.03.038Best OA location URL: https://doaj.org/article/1e207e4e620e4951aa04424fd03c5cffCitation Count: 41
-
OPENTitle: Cross‐validation of optimized composites for preclinical Alzheimer's diseaseJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 3Issue #: 1Start Page: 123End Page: 129Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.trci.2016.12.001Best OA location URL: https://doi.org/10.1016/j.trci.2016.12.001Citation Count: 23
-
OPENTitle: Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injuryJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 10Issue #: 1SStart Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2013.12.011Best OA location URL: http://doi.org/10.1016/j.jalz.2013.12.011Citation Count: 69
- What’s the target: understanding two decades of in silico microRNA-target prediction2019RESTRICTEDTitle: What’s the target: understanding two decades of in silico microRNA-target predictionJournal Name: Briefings in BioinformaticsPublisher: Oxford University Press (OUP)Vol: 21Issue #: 6Start Page: 1999End Page: 2010Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/bib/bbz111Citation Count: 51
-
OPENTitle: Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's DiseaseJournal Name: PROTEOMICSPublisher: WileyVol: 18Issue #: 20Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/pmic.201800108Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6283072Citation Count: 66
- Oxidative Damage in Parkinson's Disease2005RESTRICTEDTitle: Oxidative Damage in Parkinson's DiseaseJournal Name: Antioxidants & Redox SignalingPublisher: Mary Ann Liebert IncVol: 7Issue #: 5-6Start Page: 627End Page: 629Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1089/ars.2005.7.627Citation Count: 27
- Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double‐blind, placebo‐controlled multicenter study2017RESTRICTEDTitle: Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double‐blind, placebo‐controlled multicenter studyJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 9Start Page: 1335End Page: 1336Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27092Citation Count: 13
- Utilising functional MRI (fMRI) to explore the freezing phenomenon in Parkinson’s disease2011RESTRICTEDTitle: Utilising functional MRI (fMRI) to explore the freezing phenomenon in Parkinson’s diseaseJournal Name: Journal of Clinical NeurosciencePublisher: Elsevier BVVol: 18Issue #: 6Start Page: 807End Page: 810Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jocn.2011.02.003Citation Count: 36
-
OPENTitle: Sex differences in LRRK2 G2019S and idiopathic Parkinson's DiseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 11Start Page: 801End Page: 810Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.489Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.489Citation Count: 35
-
OPENTitle: Inflammatory profile in LRRK2-associated prodromal and clinical PDJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-016-0588-5Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-016-0588-5Citation Count: 66
-
OPENTitle: Dissecting the Binding Profile of PET Tracers to Corticobasal Degeneration Tau FibrilsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 12Issue #: 18Start Page: 3487End Page: 3496Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.1c00536Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.1c00536Citation Count: 22
-
OPENTitle: Postmortem Interval Influencesα-Synuclein Expression in Parkinson Disease BrainJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/614212Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/614212.pdfCitation Count: 12
- Synthesis of Multiring Fused 2-Pyridones via a Nitrene Insertion Reaction: Fluorescent Modulators of α-Synuclein Amyloid Formation2015RESTRICTEDTitle: Synthesis of Multiring Fused 2-Pyridones via a Nitrene Insertion Reaction: Fluorescent Modulators of α-Synuclein Amyloid FormationJournal Name: Organic LettersPublisher: American Chemical Society (ACS)Vol: 17Issue #: 24Start Page: 6194End Page: 6197Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.orglett.5b03190Citation Count: 19
-
OPENTitle: Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson’s diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-018-0596-zBest OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-018-0596-zCitation Count: 72
-
OPENTitle: Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer DiseaseJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 77Issue #: 2Start Page: 139End Page: 148Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlx110Best OA location URL: https://academic.oup.com/jnen/article-pdf/77/2/139/23373432/nlx110.pdfCitation Count: 47
-
OPENTitle: Preparation of S-glycoside surfactants and cysteine thioglycosides using minimally competent Lewis acid catalysisJournal Name: Carbohydrate ResearchPublisher: Elsevier BVVol: 422Issue #:Start Page: 1End Page: 4Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.carres.2015.12.008Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8876251Citation Count: 18
- Endogenous 2-oxoglutarate levels impact potencies of competitive HIF prolyl hydroxylase inhibitors2011RESTRICTEDTitle: Endogenous 2-oxoglutarate levels impact potencies of competitive HIF prolyl hydroxylase inhibitorsJournal Name: Pharmacological ResearchPublisher: Elsevier BVVol: 64Issue #: 3Start Page: 268End Page: 273Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.phrs.2011.03.017Citation Count: 52
-
OPENTitle: Arm swing as a potential new prodromal marker of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 10Start Page: 1527End Page: 1534Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26720Best OA location URL: http://doi.org/10.1002/mds.26720Citation Count: 163